Prevention and modulation of aminoglycoside ototoxicity (Review)

Molecular Medicine Reports

Volumn 1, Issue 1, 2008, Pages 3-13

  Perletti, Gianpaolo ^a   Vral, Anne ^b   Patrosso, Maria Cristina ^c   Marras, Emanuela ^a   Ceriani, Isabella ^a   Willems, Petra ^b   Fasano, Mauro ^a   Magri, Vittorio ^d  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b GHENT UNIVERSITY   (Belgium)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d PARKINSON INSTITUTE   (Italy)

Author keywords

Aminoglycoside; Aspirin; Gentamicin; Neomycin; Non syndromic hearing loss; Ototoxicity; Paromomycin; Streptomycin

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; BETA LACTAM; CAPREOMYCIN; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSERINE; DIBEKACIN; ETHAMBUTOL; ETHIONAMIDE; FOSFOMYCIN; GENTAMICIN; GLUTATHIONE; ISONIAZID; LEVOFLOXACIN; LINEZOLID; NEOMYCIN; OFLOXACIN; PAROMOMYCIN; PENICILLIN G; PROTIONAMIDE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; UNINDEXED DRUG; VANCOMYCIN; VIOMYCIN;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ASIAN; BACTERIAL ENDOCARDITIS; BACTERICIDAL ACTIVITY; CHINESE; CHRONIC DRUG ADMINISTRATION; COCHLEA; COCHLEA INJURY; DRUG ANALYSIS; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG ISOLATION; DRUG POTENTIATION; DRUG STRUCTURE; DRUG SUBSTITUTION; DRUG USE; ENDOCARDITIS; ENTEROCOCCAL INFECTION; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GUINEA PIG; HEARING IMPAIRMENT; HOSPITAL INFECTION; HUMAN; LOW DRUG DOSE; MOLECULAR MECHANICS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIOSIS; MYCOSIS; NEPHROTOXICITY; NEWBORN SEPSIS; NONHUMAN; OTOTOXICITY; PERITONITIS; PROSTATITIS; PSEUDOMONAS INFECTION; REVIEW; SEPTICEMIA; SOFT TISSUE INFECTION; TREATMENT DURATION; TREATMENT INDICATION; URINARY TRACT INFECTION; VESTIBULAR DISORDER; VESTIBULE;

NEGIBACTERIA;

EID: 67649143314     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Vakulenko SB and Mobashery S: Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev 16: 430-450, 2003.
2. Smith DG and Waksman SA: Tuberculostatic and tuberculocidal properties of streptomycin. J Bacteriol 54: 253-261, 1947.
3. Di Perri G and Bonora S: Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis? J Antimicrob Chemother 54: 593-602, 2004.
4. Fang GD, Brennen C, Wagener M, Swanson D, Hilf M, Zadecky L, De Vine J and Yu VL: Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study. Antimicrob Agents Chemother 35: 1849-1855, 1991.
5. Bjerklund Johansen TE, Cek M, Naber KG, Stratchounski L, Svendsen MV and Tenk P: Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and the PEAP studies. Int J Antimicrob Agents 28S: S91-S107, 2006. (Pubitemid 44163148)
6. Schaeffer AJ; National Institute of Diabetes and Digestive and Kidney Diseases of the US National Institutes of Health: NIDDK-sponsored chronic prostatitis collaborative research network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis. Int J Antimicrob Agents 24 (Suppl. 1): S49-S52, 2004.
7. Santucci RA and Krieger JN: Gentamicin for the practicing urologist: review of efficacy, single daily dosing and 'switch' therapy. J Urol 163: 1076-1084, 2000.
8. Yoshizawa S, Fourmy D and Puglisi JD: Recognition of the codon-anticodon helix by ribosomal RNA. Science 285: 1722-1725, 1999. (Pubitemid 29428870)
9. Fourmy D, Recht MI and Puglisi JD: Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 S rRNA. J Mol Biol 277: 347-362, 1998. (Pubitemid 28174973)
10. Guan MX, Fischel-Ghodsian N and Attardi G: A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity. Hum Mol Genet 9: 1787-1793, 2000. (Pubitemid 30608612)
11. Selimoglu E: Aminoglycoside-induced ototoxicity. Curr Pharm Des 13: 119-126, 2007.
12. Forge A and Schacht J: Aminoglycoside antibiotics. Audiol Neurootol 5: 3-22, 2000.
13. Takeuchi S, Ando M and Kakigi A: Mechanism generating endocochlear potential: role played by intermediate cells in stria vascularis. Biophys J 79: 2572-2582, 2000. (Pubitemid 30847856)
14. Kalkandelen S, Selimoglu E, Erdogan F, Ucuncu H and Altas E: Comparative cochlear toxicities of streptomycin, gentamicin, amikacin and netilmicin in Guinea-pigs. J Int Med Res 30: 406-412, 2002. (Pubitemid 34993565)
15. Komune S, Ide M, Nakano T and Morimitsu T: Effects of kanamycin sulfate on cochlear potentials and potassium ion permeability through the cochlear partitions. ORL J Otorhinolaryngol Relat Spec 49: 9-16, 1987. (Pubitemid 17035068)
16. Jiang H, Sha SH and Schacht J: Rac/Rho pathway regulates actin depolymerization induced by aminoglycoside antibiotics. J Neurosci Res 83: 1544-1551, 2006. (Pubitemid 43845000)
17. Kelsell DP, Di WL and Houseman MJ: Connexin mutations in skin disease and hearing loss. Am J Hum Genet 68: 559-568, 2001. (Pubitemid 32202751)
18. Petit C, Levilliers J and Hardelin JP: Molecular genetics of hearing loss. Annu Rev Genet 35: 589-646, 2001.
19. Estivill X, Fortina P, Surrey S, Rabionet R, Melchionda S, D'Agruma L, Mansfield E, Rappaport E, Govea N, Mila M, Zelante L and Gasparini P: Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet 351: 394-398, 1998. (Pubitemid 28064162)
20. Lefebvre PP and van De Water TR: Connexins, hearing and deafness: clinical aspects of mutations in the connexin 26 gene. Brain Res Brain Res Rev 32: 159-162, 2000. (Pubitemid 30177318)
21. Fischel-Ghodsian N: Mitochondrial deafness. Ear Hear 24: 303-313, 2003.
22. Van Camp G and Smith RJ: Maternally inherited hearing impairment. Clin Genet 57: 409-414, 2000.
23. Fischel-Ghodsian N: Mitochondrial mutations and hearing loss: paradigm for mitochondrial genetics. Am J Hum Genet 62: 15-19, 1998. (Pubitemid 28093828)
24. Fischel-Ghodsian N: Mitochondrial deafness mutations reviewed. Hum Mutat 13: 261-270, 1999.
25. Zhao H, Li R, Wang Q, Yan Q, Deng JH, Han D, Bai Y, Young WY and Guan MX: Maternally inherited amino-glycoside-induced and non-syndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. Am J Hum Genet 74: 139-152, 2004. (Pubitemid 38085245)
26. Zhao L, Young WY, Li R, Wang Q, Qian Y and Guan MX: Clinical evaluation and sequence analysis of the complete mitochondrial genome of three Chinese patients with hearing impairment associated with the 12S rRNA T1095C mutation. Biochem Biophys Res Commun 325: 1503-1508, 2004. (Pubitemid 39535932)
27. Casano RA, Bykhovskaya Y, Johnson DF, Hamon M, Torricelli F, Bigozzi M and Fischel-Ghodsian N: Hearing loss due to the mitochondrial A1555G mutation in Italian families. Am J Med Genet 79: 388-391, 1998. (Pubitemid 28445451)
28. Del Castillo FJ, Rodriguez-Ballesteros M, Martin Y, Arellano B, Gallo-Teran J, Morales-Angulo C, Ramirez-Camacho R, Cruz Tapia M, Solanellas J, Martinez-Conde A, Villamar M, Moreno-Pelayo MA, Moreno F and Del Castillo I: Heteroplasmy for the 1555A>G mutation in the mitochondrial 12S rRNA gene in six Spanish families with non-syndromic hearing loss. J Med Genet 40: 632-636, 2003. (Pubitemid 37046921)
29. Li Z, Li R, Chen J, Liao Z, Zhu Y, Qian Y, Xiong S, Heman-Ackah S, Wu J, Choo DI and Guan M-X: Mutational analysis of the mitochondrial 12S rRNA gene in Chinese pediatric subjects with aminoglycoside-induced and non-syndromic hearing loss. Hum Genet 117: 9-15, 2005. (Pubitemid 40778777)
30. Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu WQ, Arnos KS, Cortopassi GA, Jaber L, Rotter JI, Shohat M and Fischel-Ghodsian N: Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-induced syndromic deafness. Nat Genet 4: 289-294, 1993. (Pubitemid 23205179)
31. Li X, Li R, Lin X and Guan MX: Isolation and characterization of the putative nuclear modifier gene MTO1 involved in the pathogenesis of deafness-associated mitochondrial 12 S rRNA A1555G mutation. J Biol Chem 277: 27256-27264, 2002. (Pubitemid 34951743)
32. Malik SG, Pieter N, Sudoyo H, Kadir A and Marzuki S: Prevalence of the mitochondrial DNA A1555G mutation in sensorineural deafness patients in island Southeast Asia. J Hum Genet 48: 480-483, 2003. (Pubitemid 37295605)
33. Jhee SS, Burm JP and Gill MA: Comparison of aminoglycoside pharmacokinetics in Asian, Hispanic, and Caucasian patients by using population pharmacokinetic methods. Antimicrob Agents Chemother 38: 2073-2077, 1994.
34. Fischel-Ghodsian N, Prezant TR, Chaltraw WE, Wendt KA, Nelson RA, Arnos KS and Falk RE: Mitochondrial gene mutation is a significant predisposing factor in aminoglycoside ototoxicity. Am J Otolaryngol 18: 173-178, 1997. (Pubitemid 27215295)
35. Jacobs HT, Hutchin TP, Käppi T, Gillies G, Minkkinen K, Walker J, Thompson K, Rovio AT, Carella M, Melchionda S, Zelante L, Gasparini P, Pyykkö I, Shah ZH, Zeviani M and Mueller RF: Mitochondrial DNA mutations in patients with postlingual, non-syndromic hearing impairment. Eur J Hum Genet 13: 26-33, 2005.
36. Tessa A, Giannotti A, Tieri L, Vilarinho L, Marotta G and Santorelli FM: Maternally inherited deafness associated with a T1095C mutation in the mDNA. Eur J Hum Genet 9: 147-149, 2001. (Pubitemid 32156697)
37. Zhao H, Young WY, Yan Q, Li R, Cao J, Wang Q, Li X, Peters JL, Han D and Guan MX: Functional characterization of the mitochondrial 12S rRNA C1494T mutation associated with aminoglycoside-induced and non-syndromic hearing loss. Nucleic Acids Res 33: 1132-1139, 2005. (Pubitemid 41430533)
38. Hutchin T and Cortopassi G: Proposed molecular and cellular mechanism for aminoglycoside ototoxicity. Antimicrob Agents Chemother 38: 2517-2520, 1994. (Pubitemid 24332579)
39. Ohtani I, Ohtsuki K, Aikawa T, Sato Y, Anzai T and Ouchi J: Mechanism of protective effect of fosfomycin against aminoglycoside ototoxicity. Auris Nasus Larynx 11: 119-124, 1984. (Pubitemid 15175641)
40. Nishida I and Takumida M: Attenuation of aminoglycoside ototoxicity by glutathione. ORL J Otorhinolaryngol Relat Spec 58: 68-73, 1996.
41. Garetz SL, Altschuler RA and Schacht J: Attenuation of gentamicin ototoxicity by glutathione in the guinea pig in vivo. Hear Res 77: 81-87, 1994. (Pubitemid 24201332)
42. Conlon BJ and Smith DW: Topical aminoglycoside ototoxicity: attempting to protect the cochlea. Acta Otolaryngol 120: 596-599, 2000. (Pubitemid 32521208)
43. Momiyama J, Hashimoto T, Matsubara A, Futai K, Namba A and Shinkawa H: Leupeptin, a calpain inhibitor, protects inner ear hair cells from aminoglycoside ototoxicity. Tohoku J Exp Med 209: 89-97, 2006. (Pubitemid 43757426)
44. Ding D, Stracher A and Salvi RJ: Leupeptin protects cochlear and vestibular hair cells from gentamicin ototoxicity. Hear Res 164: 115-126, 2002. (Pubitemid 34285584)
45. Himeno C, Komeda M, Izumikawa M, Takemura K, Yagi M, Weiping Y, Doi T, Kuriyama H, Miller JM and Yamashita T: Intracochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res 167: 61-70, 2002. (Pubitemid 34756851)
46. Chu HQ, Xiong H, Zhou XQ, Han F, Wu ZG, Zhang P, Huang XW and Cui YH: Aminoglycoside ototoxicity in three murine strains and effects on NKCC1 of stria vascularis. Chin Med J 119: 980-985, 2006. (Pubitemid 43960077)
47. Song BB, Sha SH and Schacht J: Iron chelators protect from aminoglycoside-induced cochleo- and vestibulo-toxicity. Free Radic Biol Med 25: 189-195, 1998.
48. Jiang H, Sha SH and Schacht J: NF-kappaB pathway protects cochlear hair cells from aminoglycoside-induced ototoxicity. J Neurosci Res 79: 644-651, 2005. (Pubitemid 40476443)
49. Conlon BJ, Perry BP and Smith DW: Attenuation of neomycin ototoxicity by iron chelation. Laryngoscope 108: 284-287, 1998.
50. Sinswat P, Wu WJ, Sha SH and Schacht J: Protection from ototoxicity of intraperitoneal gentamicin in guinea pig. Kidney Int 58: 2525-2532, 2000.
51. Jiang H, Sha SH and Schacht J: NF-kappaB pathway protects cochlear hair cells from aminoglycoside-induced ototoxicity. J Neurosci Res 79: 644-651, 2005. (Pubitemid 40476443)
52. Sha SH and Schacht J: Salicylate attenuates gentamicin-induced ototoxicity. Lab Invest 79: 807-813, 1999.
53. Sha S-H, Qiu J-H and Schacht J: Aspirin attenuates gentamicin-induced hearing loss. N Engl J Med 354: 1856-1857, 2006.
54. Chen Y, Huang WG, Zha DJ, Qiu JH, Wang JL, Sha SH and Schacht J: Aspirin attenuates gentamicin ototoxicity: from the laboratory to the clinic. Hear Res 226: 178-182, 2007. (Pubitemid 46428024)
55. Wang AM, Sha SH, Lesniak W and Schacht J: Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo. Antimicrob Agents Chemother 47: 1836-1841, 2003.
56. Kimura N, Nishizaki K, Orita Y and Masuda Y: 4-methylcatechol, a potent inducer of nerve growth factor synthesis, protects spiral ganglion neurons from aminoglycoside ototoxicity - preliminary report. Acta Otolaryngol Suppl 540: 12-15, 1999. (Pubitemid 29336465)
57. Zheng JL and Gao WQ: Concanavalin A protects hair cells against gentamicin ototoxicity in rat cochlear explant cultures. J Neurobiol 39: 29-40, 1999.
58. Unal OF, Ghoreishi SM, Atas A, Akyurek N, Akyol G and Gursel B: Prevention of gentamicin induced ototoxicity by trimetazidine in animal model. Int J Pediatr Otorhinolaryngol 69: 193-199, 2005. (Pubitemid 40126746)
59. Long M, Smouha EE, Qiu D, Li F, Johnson F and Luft B: Flavonoid of Drynaria fortunei protects against gentamicin ototoxicity. Phytother Res 18: 609-614, 2004. (Pubitemid 39329708)
60. Low W, Dazert S, Baird A and Ryan AF: Basic fibroblast growth factor (FGF-2) protects rat cochlear hair cells in organotypical culture from aminoglycoside injury. J Cell Physiol 167: 443-450, 1996. (Pubitemid 26168220)
61. Staecker H, Dazert S, Malgrange B, Lefebvre PP, Ryan AF and van de Water TR: Transforming growth factor alpha treatment alters intracellular calcium levels in hair cells and protects them from ototoxic damage in vitro. Int J Dev Neurosci 15: 553-562, 1997. (Pubitemid 27332105)
62. McFadden SL, Ding D, Salvemini D and Salvi RJ: M40403, a superoxide dismutase mimetic, protects cochlear hair cells from gentamicin, but not cisplatin toxicity. Toxicol Appl Pharmacol 186: 46-54, 2003. (Pubitemid 36262948)
63. Yarin YM, Amarjargal N, Fuchs J, Haupt H, Mazurek B, Morozova SV and Gross J: Argon protects hypoxia-, cisplatin- and gentamicin-exposed hair cells in the newborn rat's organ of Corti. Hear Res 201: 1-9, 2005. (Pubitemid 40255539)
64. Sha SH and Schacht J: Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential protectant. Hear Res 142: 34-40, 2000.
65. Kashio A, Sakamoto T, Suzukawa K, Asoh S, Ohta S and Yamasoba T: A protein derived from the fusion of TAT peptide and FNK, a Bcl-x(L) derivative, prevents cochlear hair cell death from aminoglycoside ototoxicity in vivo. J Neurosci Res 85: 1403-1412, 2007. (Pubitemid 46724383)
66. Duan M, Agerman K, Ernfors P and Canlon B: Complementary roles of neurotrophin 3 and a N-methyl-D-aspartate antagonist in the protection of noise and aminoglycoside-induced ototoxicity. Proc Natl Acad Sci USA 97: 7597-7602, 2000. (Pubitemid 30431509)
67. Basile AS, Huang JM, Xie C, Webster D, Berlin C and Skolnick P: N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss. Nat Med 2: 1338-1343, 1996. (Pubitemid 26401736)
68. Sha SH and Schacht J: Are aminoglycoside antibiotics excitotoxic? Neuroreport 9: 3893-3895, 1998.
69. Oliveira JA, Canedo DM, Rossato M and Andrade MH: Self-protection against aminoglycoside ototoxicity in guinea pigs. Otolaryngol Head Neck Surg 131: 271-279, 2004. (Pubitemid 39208706)
70. Hester TO, Jones RO and Clerici WJ: Protection against aminoglycoside otic drop-induced ototoxicity by a spin trap: I. Acute effects. Otolaryngol Head Neck Surg 119: 581-587, 1998.
71. Bailey RR, Begg EJ, Smith AH, Robson RA, Lynn KL, Chambers ST, Barclay ML and Hornibrook J: Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis. Clin Nephrol 46: 183-186, 1996.